Gabriel De la Cruz Ku
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gabriel De la Cruz Ku has a total of 384 co-authors. Here are the top co-authors by number of shared publications:
Anshumi Desai
Department of Plastic Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
15 shared publicationsBryan Valcarcel
Affiliation The George Washington University, Washington DC, United States of America
11 shared publications- Daniel Enriquez
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
11 shared publications - Bryan Valcarcel
Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX
10 shared publications - Diego Chambergo-Michilot
Universidad Científica del Sur, Lima, Perú
10 shared publications Daniel Enriquez-Vera
Universidad Privada San Juan Bautista
9 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (11) , e0361867
Clinicopathologic characteristics and survival outcomes of gastroenteropancreatic neuroendocrine neoplasms in Peru: A 15-year retrospective cohort study
Introduction: Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) has increased globally; however, data from Latin America remain scarce. This study aimed to describe the sociodemographic and clinicopathologic characteristics, treatment modalities, survival outcomes, and prognostic factors of GEP-NENs in a 15-year single-center cohort at a national referral cancer center in Lima, Peru. Materials and methods: We conducted a retrospective, hospital-based cohort study. Patients diagnosed with GEP-NENs at the Instituto Nacional de Enfermedades Neoplásicas (INEN) were included from 2009 to 2024, and tumors were classified according to the 2019 WHO Classification of GEP-NENs. Overall survival (OS) was estimated using Kaplan-Meier curves and compared using the log-rank test. Prognostic factors were identified through Cox proportional hazards models. Results: Three hundred sixty-eight patients were included. The median age at diagnosis was 57 years, with a female predominance (56.2%). Most patients presented with an ECOG performance status of 0–1 (96.5%), and among patients with available disease-extent information, 64.7% had non-metastatic disease. The majority of tumors were well-differentiated (neuroendocrine tumors [NETs]) (84.2%), while 15.8% were poorly differentiated (neuroendocrine carcinomas [NECs]). The most common primary tumor sites included the rectum (39.1%), stomach (19.8%), and pancreas (18.8%). With a median follow-up of 61.9 months, the 5-year OS rate was 52%. NETs exhibited longer OS than NECs, with 5-year OS rates of 65% and 8%, respectively (log-rank p < 0.001). In the multivariable analysis, metastatic disease (aHR = 2.61, 95% CI: 1.63–4.20; p < 0.001) and poorly differentiated histology (aHR: 4.36, 95% CI: 2.59–7.31; p < 0.001) were independently associated with worse overall survival, whereas surgery (aHR: 0.25, 95% CI: 0.15–0.41; p < 0.001) and systemic treatment (aHR: 0.53, 95% CI: 0.31–0.92; p = 0.024) were associated with improved overall survival. Conclusion: Our findings demonstrate that GEP-NENs represent a highly heterogeneous group of neoplasms with substantial variability in clinicopathological characteristics and survival outcomes. Most patients in our cohort had well-differentiated NETs and favorable long-term survival. These findings support the need for comprehensive national registries and multicenter collaborative studies to validate our results and better characterize GEP-NENs in underrepresented Latin American populations.
- 5 November 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (11) , e0361867
Open AccessClinicopathologic characteristics and survival outcomes of gastroenteropancreatic neuroendocrine neoplasms in Peru: A 15-year retrospective cohort study
Introduction: Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) has increased globally; however, data from Latin America remain scarce. This study aimed to describe the sociodemographic and clinicopathologic characteristics, treatment modalities, survival outcomes, and prognostic factors of GEP-NENs in a 15-year single-center cohort at a national referral cancer center in Lima, Peru. Materials and methods: We conducted a retrospective, hospital-based cohort study. Patients diagnosed with GEP-NENs at the Instituto Nacional de Enfermedades Neoplásicas (INEN) were included from 2009 to 2024, and tumors were classified according to the 2019 WHO Classification of GEP-NENs. Overall survival (OS) was estimated using Kaplan-Meier curves and compared using the log-rank test. Prognostic factors were identified through Cox proportional hazards models. Results: Three hundred sixty-eight patients were included. The median age at diagnosis was 57 years, with a female predominance (56.2%). Most patients presented with an ECOG performance status of 0–1 (96.5%), and among patients with available disease-extent information, 64.7% had non-metastatic disease. The majority of tumors were well-differentiated (neuroendocrine tumors [NETs]) (84.2%), while 15.8% were poorly differentiated (neuroendocrine carcinomas [NECs]). The most common primary tumor sites included the rectum (39.1%), stomach (19.8%), and pancreas (18.8%). With a median follow-up of 61.9 months, the 5-year OS rate was 52%. NETs exhibited longer OS than NECs, with 5-year OS rates of 65% and 8%, respectively (log-rank p < 0.001). In the multivariable analysis, metastatic disease (aHR = 2.61, 95% CI: 1.63–4.20; p < 0.001) and poorly differentiated histology (aHR: 4.36, 95% CI: 2.59–7.31; p < 0.001) were independently associated with worse overall survival, whereas surgery (aHR: 0.25, 95% CI: 0.15–0.41; p < 0.001) and systemic treatment (aHR: 0.53, 95% CI: 0.31–0.92; p = 0.024) were associated with improved overall survival. Conclusion: Our findings demonstrate that GEP-NENs represent a highly heterogeneous group of neoplasms with substantial variability in clinicopathological characteristics and survival outcomes. Most patients in our cohort had well-differentiated NETs and favorable long-term survival. These findings support the need for comprehensive national registries and multicenter collaborative studies to validate our results and better characterize GEP-NENs in underrepresented Latin American populations.
- 21 October 2026
- Published by Wiley in Journal of Surgical Oncology
Perioperative Outcomes of the Modified Oncoplastic Lift and Lymphatic Excision and Reconstruction (MOLLER) Technique in Breast Surgery
Background and Objectives: Oncoplastic breast surgery integrates oncologic resection with reconstructive techniques to optimize both tumor control and aesthetic outcomes. The Modified Oncoplastic Lift and Lymphatic Excision and Reconstruction (MOLLER) technique is a reconstructive approach incorporating lymphatic preservation principles while aiming to preserve breast contour. However, perioperative outcomes remain incompletely characterized. Methods: A single‐center retrospective cohort study included adult women undergoing partial mastectomy or lumpectomy for malignant or benign breast conditions with the MOLLER technique (2011–2021). Primary outcomes were immediate and delayed postoperative complications; secondary outcomes were re‐excision and radiation‐related complications. Results: A total of 136 patients were included. Median follow‐up was 3 years. Immediate complications were infrequent: hematoma and wound dehiscence each occurred in 3 patients (2.2%); seroma, infection, and paresthesia each in 2 (1.5%). Delayed complications were uncommon: arm lymphedema in 5 patients (3.7%); fat necrosis and breast lymphedema each in 4 (2.9%). The re‐excision rate was 4.4%. Radiation‐related complications were uncommon, most commonly skin discoloration (7.4%) and skin thickening (5.1%); no delayed wound healing occurred. Conclusions: The MOLLER technique is a safe reconstructive approach associated with low rates of postoperative complications, re‐excision, and lymphedema. Its lymphatic preservation principles may be associated with reduced lymphatic morbidity. Prospective studies are warranted to validate these findings.
- 21 October 2026
- Published by Wiley in Journal of Surgical Oncology
Perioperative Outcomes of the Modified Oncoplastic Lift and Lymphatic Excision and Reconstruction (MOLLER) Technique in Breast Surgery
Background and Objectives: Oncoplastic breast surgery integrates oncologic resection with reconstructive techniques to optimize both tumor control and aesthetic outcomes. The Modified Oncoplastic Lift and Lymphatic Excision and Reconstruction (MOLLER) technique is a reconstructive approach incorporating lymphatic preservation principles while aiming to preserve breast contour. However, perioperative outcomes remain incompletely characterized. Methods: A single‐center retrospective cohort study included adult women undergoing partial mastectomy or lumpectomy for malignant or benign breast conditions with the MOLLER technique (2011–2021). Primary outcomes were immediate and delayed postoperative complications; secondary outcomes were re‐excision and radiation‐related complications. Results: A total of 136 patients were included. Median follow‐up was 3 years. Immediate complications were infrequent: hematoma and wound dehiscence each occurred in 3 patients (2.2%); seroma, infection, and paresthesia each in 2 (1.5%). Delayed complications were uncommon: arm lymphedema in 5 patients (3.7%); fat necrosis and breast lymphedema each in 4 (2.9%). The re‐excision rate was 4.4%. Radiation‐related complications were uncommon, most commonly skin discoloration (7.4%) and skin thickening (5.1%); no delayed wound healing occurred. Conclusions: The MOLLER technique is a safe reconstructive approach associated with low rates of postoperative complications, re‐excision, and lymphedema. Its lymphatic preservation principles may be associated with reduced lymphatic morbidity. Prospective studies are warranted to validate these findings.
- Open Access
- 23 September 2026
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 22 (4) , 455-465
Versatility of Lateral Intercostal Artery Perforator Flaps in Partial Breast Reconstruction: First National Experience of Peru
Versatility of Lateral Intercostal Artery Perforator Flaps in Partial Breast Reconstruction: First National Experience of Peru - European Journal of Breast Health
- 23 September 2026
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 22 (4) , 455-465
Open AccessVersatility of Lateral Intercostal Artery Perforator Flaps in Partial Breast Reconstruction: First National Experience of Peru
Versatility of Lateral Intercostal Artery Perforator Flaps in Partial Breast Reconstruction: First National Experience of Peru - European Journal of Breast Health
- 6 September 2026
- Published by SAGE Publications in Journal of Adolescent and Young Adult Oncology
Clinical Characteristics and Outcomes of Melanoma Among Latin American Adolescents and Young Adults Compared to Middle-Aged and Elderly Population: A Cohort Analysis Over 10 Years
Introduction: Outcomes among the Hispanic population are rarely explored in adolescents and young adults (AYAs). We aimed to compare sociodemographic, clinical, and survival outcomes of Latin American AYAs (≤39 years) with middle-aged (40–59 years) and older (≥60 years) patients with melanoma. Methods: A single-center retrospective cohort study among patients with melanoma stages I–IV was conducted in Lima, Peru, from 2010 to 2019. We evaluated overall survival (OS), event-free survival (EFS) rates, and prognostic factors. Results: Of 1121 patients with melanoma, 118 (10.5%) were AYAs, 357 (31.9%) were middle-aged, and 645 (57.6%) were elderly. Less frequencies of lower extremity as primary site (56.8%, 68.9%, and 82.3%, p < 0.01), ulceration (46.8%, 58.8%, 72.5%, p < 0.01), and acral histology (22.6%, and 32.8%, and 44.3%, p < 0.01) were present in AYAs. Moreover, AYAs had a higher frequency of American Joint Committee on Cancer stages I (16.1%, 10.1%, and 7.9%) and IV (25.4%, 24.6%, and 21.9%, p < 0.01). AYAs had less frequent adjuvant chemotherapy (10.3%, 18.4%, and 11.2%, p = 0.03). With a median follow-up of 9.8 years, the 5-year OS and EFS rates for AYAs (52%, 32%) were better than the middle-aged (43%, 23%) and older population (32%, 15%) ( p < 0.01). Multivariate analyses showed that AYAs had better prognosis than elderly population (≥60 years, hazard ratio = 1.93). Conclusions: Latin American AYAs with melanoma had less aggressive tumor characteristics and received less systemic therapy compared to middle-aged patients, yet demonstrated better EFS and OS rates across all age groups. Therefore, younger age is not a risk factor for worse survival outcomes. Given the relatively high frequency of stage IV disease in AYAs, it is crucial to develop strategies for early detection in the primary care setting.
- 6 September 2026
- Published by SAGE Publications in Journal of Adolescent and Young Adult Oncology
Clinical Characteristics and Outcomes of Melanoma Among Latin American Adolescents and Young Adults Compared to Middle-Aged and Elderly Population: A Cohort Analysis Over 10 Years
Introduction: Outcomes among the Hispanic population are rarely explored in adolescents and young adults (AYAs). We aimed to compare sociodemographic, clinical, and survival outcomes of Latin American AYAs (≤39 years) with middle-aged (40–59 years) and older (≥60 years) patients with melanoma. Methods: A single-center retrospective cohort study among patients with melanoma stages I–IV was conducted in Lima, Peru, from 2010 to 2019. We evaluated overall survival (OS), event-free survival (EFS) rates, and prognostic factors. Results: Of 1121 patients with melanoma, 118 (10.5%) were AYAs, 357 (31.9%) were middle-aged, and 645 (57.6%) were elderly. Less frequencies of lower extremity as primary site (56.8%, 68.9%, and 82.3%, p < 0.01), ulceration (46.8%, 58.8%, 72.5%, p < 0.01), and acral histology (22.6%, and 32.8%, and 44.3%, p < 0.01) were present in AYAs. Moreover, AYAs had a higher frequency of American Joint Committee on Cancer stages I (16.1%, 10.1%, and 7.9%) and IV (25.4%, 24.6%, and 21.9%, p < 0.01). AYAs had less frequent adjuvant chemotherapy (10.3%, 18.4%, and 11.2%, p = 0.03). With a median follow-up of 9.8 years, the 5-year OS and EFS rates for AYAs (52%, 32%) were better than the middle-aged (43%, 23%) and older population (32%, 15%) ( p < 0.01). Multivariate analyses showed that AYAs had better prognosis than elderly population (≥60 years, hazard ratio = 1.93). Conclusions: Latin American AYAs with melanoma had less aggressive tumor characteristics and received less systemic therapy compared to middle-aged patients, yet demonstrated better EFS and OS rates across all age groups. Therefore, younger age is not a risk factor for worse survival outcomes. Given the relatively high frequency of stage IV disease in AYAs, it is crucial to develop strategies for early detection in the primary care setting.
- Open Access
- 25 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0356381
Primary ocular-adnexal non-Hodgkin Lymphoma in a Peruvian cohort: An 18-year experience
Background: Primary ocular-adnexal non-Hodgkin lymphoma (POANHL) is a rare malignancy, but the most common tumor of the ocular adnexa. Data on real-world outcomes in Hispanic-Latino populations are limited, despite potential geographic and biologic differences. We describe the treatment and outcomes of POANHL in a Peruvian cohort and identify factors associated with survival outcomes. Methods: We conducted a retrospective cohort study including all patients diagnosed with localized POANHL (stage I and II) at a tertiary referral center between 2000 and 2017. Survival outcomes were estimated using Kaplan–Meier methods, and Cox proportional hazards models were used to identify prognostic factors for event-free survival (EFS) and overall survival (OS). Results: A total of 98 patients were included. The mean age was 58.0 ± 17.5 years. The orbit was the most frequently involved site (42.8%), followed by the eyelid (29.6%) and the conjunctiva (27.6%). The most common associated lymphomas were extranodal marginal zone lymphoma (50.0%), diffuse large B-cell lymphoma (23.5%), and follicular lymphoma (7.1%). Most patients presented with stage I disease (80.6%), good performance status (ECOG 0–1: 88.8%), and low international prognostic index (0–1: 69.6%). Treatment included chemotherapy (39.2%), radiotherapy (24.5%), combined modality therapy (12.2%), and observation/no treatment (35.7%). Cyclophosphamide, vincristine, doxorubicin, and prednisone-based regimens were the most commonly used chemotherapy backbone. Complete response (CR) was 45.6% among treated patients. With a median follow-up of 20.2 years, 5-year OS and EFS were 94.8% and 79.2% for indolent lymphomas, and 59.7% and 42.8% for aggressive lymphomas respectively. On multivariable analysis, older age was independently associated with worse outcomes in indolent lymphoma, both for EFS (HR = 1.084, 95%CI 1.028–1.142) and OS (HR = 1.092, 95%CI: 1.037–1.150). In aggressive lymphoma, treatment modality was the only independent prognostic factor for DFS, with chemotherapy (HR 0.135, 95% CI 0.031–0.595; p = 0.008) and chemoradiotherapy (HR 0.112, 95% CI 0.023–0.547; p = 0.007) associated with improved outcomes vs. observation; radiotherapy showed a non-significant trend (HR = 0.200, 95%:CI 0.033–1.203). No variables were independently associated with OS in aggressive lymphoma. Conclusions: We report real-world outcomes of POANHL in a Hispanic–Latino cohort, demonstrating distinct clinical characteristics and survival outcomes compared with previously published series.
- 25 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0356381
Open AccessPrimary ocular-adnexal non-Hodgkin Lymphoma in a Peruvian cohort: An 18-year experience
Background: Primary ocular-adnexal non-Hodgkin lymphoma (POANHL) is a rare malignancy, but the most common tumor of the ocular adnexa. Data on real-world outcomes in Hispanic-Latino populations are limited, despite potential geographic and biologic differences. We describe the treatment and outcomes of POANHL in a Peruvian cohort and identify factors associated with survival outcomes. Methods: We conducted a retrospective cohort study including all patients diagnosed with localized POANHL (stage I and II) at a tertiary referral center between 2000 and 2017. Survival outcomes were estimated using Kaplan–Meier methods, and Cox proportional hazards models were used to identify prognostic factors for event-free survival (EFS) and overall survival (OS). Results: A total of 98 patients were included. The mean age was 58.0 ± 17.5 years. The orbit was the most frequently involved site (42.8%), followed by the eyelid (29.6%) and the conjunctiva (27.6%). The most common associated lymphomas were extranodal marginal zone lymphoma (50.0%), diffuse large B-cell lymphoma (23.5%), and follicular lymphoma (7.1%). Most patients presented with stage I disease (80.6%), good performance status (ECOG 0–1: 88.8%), and low international prognostic index (0–1: 69.6%). Treatment included chemotherapy (39.2%), radiotherapy (24.5%), combined modality therapy (12.2%), and observation/no treatment (35.7%). Cyclophosphamide, vincristine, doxorubicin, and prednisone-based regimens were the most commonly used chemotherapy backbone. Complete response (CR) was 45.6% among treated patients. With a median follow-up of 20.2 years, 5-year OS and EFS were 94.8% and 79.2% for indolent lymphomas, and 59.7% and 42.8% for aggressive lymphomas respectively. On multivariable analysis, older age was independently associated with worse outcomes in indolent lymphoma, both for EFS (HR = 1.084, 95%CI 1.028–1.142) and OS (HR = 1.092, 95%CI: 1.037–1.150). In aggressive lymphoma, treatment modality was the only independent prognostic factor for DFS, with chemotherapy (HR 0.135, 95% CI 0.031–0.595; p = 0.008) and chemoradiotherapy (HR 0.112, 95% CI 0.023–0.547; p = 0.007) associated with improved outcomes vs. observation; radiotherapy showed a non-significant trend (HR = 0.200, 95%:CI 0.033–1.203). No variables were independently associated with OS in aggressive lymphoma. Conclusions: We report real-world outcomes of POANHL in a Hispanic–Latino cohort, demonstrating distinct clinical characteristics and survival outcomes compared with previously published series.
- Open Access
- 23 July 2026
- Published by Elsevier in JPRAS Open
- Vol. 51, 544-551
Delabeling penicillin allergies in plastic and reconstructive surgery: Cefazolin as the cornerstone for antibiotic prophylaxis
- 23 July 2026
- Published by Elsevier in JPRAS Open
- Vol. 51, 544-551
Open AccessDelabeling penicillin allergies in plastic and reconstructive surgery: Cefazolin as the cornerstone for antibiotic prophylaxis
- 12 May 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1)
Comparison of short-term outcomes between open and minimally invasive surgery for emergent parastomal hernia repair: A retrospective propensity score–matched analysis
Parastomal hernia (PSH) is a common complication after stoma creation and may present emergently with obstruction, incarceration, or ischemia. While minimally invasive surgery (MIS, laparoscopic or robotic) shows benefits in elective PSH repair, data in emergencies are limited. This study compared outcomes following open versus MIS emergent PSH repair. In this retrospective cohort using ACS-NSQIP, patients undergoing emergent open, laparoscopic, or robotic PSH repair were identified. Surgical approach was categorized as open or MIS. A 3:1 propensity score-matched analysis balanced demographic, comorbidity, physiologic, laboratory, and operative variables. Primary outcome was 30-day overall postoperative complications; secondary outcomes included wound, medical, and surgical complications, return to the operating room (OR), length of stay, and readmission. Multivariate logistic regression identified predictors of complications. Of 303 patients (249 open, 54 MIS), 192 were analyzed after matching (144 open, 48 MIS) with balanced baseline characteristics. MIS repair had lower overall complications than open repair (22.9% vs. 39.6%, p = 0.037), while wound, medical, and surgical complications were similar. Return to the OR tended to be higher after MIS (14.6% vs. 6.3%, p = 0.070), mainly for ostomy-related revisions. Length of stay and readmission were comparable. Higher ASA class independently predicted complications. Robotic repair was associated with reduced odds of overall complications (OR 0.35; 95% CI 0.15-0.79; p = 0.012). MIS repair of emergent PSH was associated with fewer overall complications, though ostomy-related reoperations may be more frequent. MIS is a safe option in selected high-risk patients, with approach guided by patient factors and surgeon experience.
- 12 May 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1)
Comparison of short-term outcomes between open and minimally invasive surgery for emergent parastomal hernia repair: A retrospective propensity score–matched analysis
Parastomal hernia (PSH) is a common complication after stoma creation and may present emergently with obstruction, incarceration, or ischemia. While minimally invasive surgery (MIS, laparoscopic or robotic) shows benefits in elective PSH repair, data in emergencies are limited. This study compared outcomes following open versus MIS emergent PSH repair. In this retrospective cohort using ACS-NSQIP, patients undergoing emergent open, laparoscopic, or robotic PSH repair were identified. Surgical approach was categorized as open or MIS. A 3:1 propensity score-matched analysis balanced demographic, comorbidity, physiologic, laboratory, and operative variables. Primary outcome was 30-day overall postoperative complications; secondary outcomes included wound, medical, and surgical complications, return to the operating room (OR), length of stay, and readmission. Multivariate logistic regression identified predictors of complications. Of 303 patients (249 open, 54 MIS), 192 were analyzed after matching (144 open, 48 MIS) with balanced baseline characteristics. MIS repair had lower overall complications than open repair (22.9% vs. 39.6%, p = 0.037), while wound, medical, and surgical complications were similar. Return to the OR tended to be higher after MIS (14.6% vs. 6.3%, p = 0.070), mainly for ostomy-related revisions. Length of stay and readmission were comparable. Higher ASA class independently predicted complications. Robotic repair was associated with reduced odds of overall complications (OR 0.35; 95% CI 0.15-0.79; p = 0.012). MIS repair of emergent PSH was associated with fewer overall complications, though ostomy-related reoperations may be more frequent. MIS is a safe option in selected high-risk patients, with approach guided by patient factors and surgeon experience.
- Open Access
- 30 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0347763
Robotic versus open component separation: A retrospective cohort and propensity score analysis of complication rates and clinical outcomes
Background: Complex ventral hernias are a surgical challenge associated with high morbidity and healthcare costs. Component separation techniques have improved throughout the years with better outcomes, although the optimal approach remains debated. Robotic surgery has shown promising outcomes as an alternative to open repair, although data in large multicenter studies is still limited. Methods: A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Adult patients undergoing component separation for ventral hernia repair were identified using CPT and ICD codes. Outcomes included 30-day surgical, wound, medical, and overall complications, as well as length of stay and readmission. Multivariable logistic regression and propensity score matching were applied to adjust for baseline differences. Results: A total of 6,207 patients were included, from those 4,443 (71.6%) underwent open technique and 1,764 (28.4%) robotic. After propensity matching (n = 5,259), robotic repair was independently associated with significantly lower overall complication rates (4.8% vs. 19.6%, aOR 0.193, 95% CI 0.140–0.265, p < 0.001), including wound (2.2% vs. 10.2%, aOR 0.164, p < 0.001), surgical (2.9% vs. 10.0%, aOR 0.271, p < 0.001), and medical complications (2.0% vs. 7.0%, aOR 0.229, p < 0.001). Robotic surgery was also associated with shorter length of stay (1.34 vs. 3.86 days, p < 0.001) and lower readmission rates (4.4% vs. 9.1%, p < 0.001). Conclusions: Robotic component separation for ventral hernia repair is associated with lower postoperative complication rates, shorter length of stay, and fewer readmissions compared to the open approach. These benefits remained significant after multivariate analysis and propensity score matching, supporting the robotic technique as an effective strategy. Prospective studies are warranted to evaluate long-term outcomes, including recurrence, and to assess cost-effectiveness to optimize evidence-based surgical decision-making.
- 30 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0347763
Open AccessRobotic versus open component separation: A retrospective cohort and propensity score analysis of complication rates and clinical outcomes
Background: Complex ventral hernias are a surgical challenge associated with high morbidity and healthcare costs. Component separation techniques have improved throughout the years with better outcomes, although the optimal approach remains debated. Robotic surgery has shown promising outcomes as an alternative to open repair, although data in large multicenter studies is still limited. Methods: A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Adult patients undergoing component separation for ventral hernia repair were identified using CPT and ICD codes. Outcomes included 30-day surgical, wound, medical, and overall complications, as well as length of stay and readmission. Multivariable logistic regression and propensity score matching were applied to adjust for baseline differences. Results: A total of 6,207 patients were included, from those 4,443 (71.6%) underwent open technique and 1,764 (28.4%) robotic. After propensity matching (n = 5,259), robotic repair was independently associated with significantly lower overall complication rates (4.8% vs. 19.6%, aOR 0.193, 95% CI 0.140–0.265, p < 0.001), including wound (2.2% vs. 10.2%, aOR 0.164, p < 0.001), surgical (2.9% vs. 10.0%, aOR 0.271, p < 0.001), and medical complications (2.0% vs. 7.0%, aOR 0.229, p < 0.001). Robotic surgery was also associated with shorter length of stay (1.34 vs. 3.86 days, p < 0.001) and lower readmission rates (4.4% vs. 9.1%, p < 0.001). Conclusions: Robotic component separation for ventral hernia repair is associated with lower postoperative complication rates, shorter length of stay, and fewer readmissions compared to the open approach. These benefits remained significant after multivariate analysis and propensity score matching, supporting the robotic technique as an effective strategy. Prospective studies are warranted to evaluate long-term outcomes, including recurrence, and to assess cost-effectiveness to optimize evidence-based surgical decision-making.